2016-2019 Innovation Research Grant Recipients
Throughout 2016-2019 CANFAR invested over $800,000 in support of HIV and AIDS research.
This research covers all aspects of HIV prevention, treatment, care and the search for a cure. In total, CANFAR has 31 open research projects that are being funded. These are all broken down below under the main categories.
There are several key populations that are disproportionately affected by HIV in Canada. These include gay and bisexual men, transwomen, indigenous populations, injecting drug users, youth under age 29, and immigrant populations.
Prevention Research is critical to understanding the key populations, and developing effective strategies for preventing new infections. These include psychosocial studies, studies evaluating current prevention strategies, piloting new initiatives, and exploring important preventative drug initiatives.
CANFAR has funded over $4,500,000 towards prevention research since its inception. Below are the leading prevention research studies funded by CANFAR.
Advances in treatment have helped ensure that people living with HIV can have long and healthy lives. However, treatment can have many side effects and people living with HIV can face multiple barriers to accessing treatment.
Of the 36 million people living with HIV globally, only 77% who know their status are receiving treatment. Research is still needed to improve the effectiveness of drugs and improve access to and quality of health care for people living with HIV.
CANFAR has funded over $4.5 million in research related to HIV treatment, which includes the development of modern and life-saving HIV treatment.
Addressing the care needs of people living with HIV is crucial to its management and effective treatment. However, there are still knowledge gaps with many aspects of care.
Such aspects include the psychosocial, socioeconomic, and mental health needs of people living with HIV. Educating medical personnel to effectively care for HIV+ patients is also a topic of research. For people living with HIV, care is crucial for positive treatment outcomes.
CANFAR has funded $3 million in research related to HIV care, contributing to improving the needs of HIV patients.
Research advancements have transformed HIV into a chronic, manageable disease. Treatment, however, is a daily, life-long regimen for a person living with HIV.
In Canada, the cost of treating HIV over one person’s lifetime is estimated to be $250,000. A cure is essential to ending HIV and AIDS.
CANFAR has invested over $8.5 million in cure research, including a promising national research collaboration studying new approaches to curing HIV infection.